Patent classifications
A61B2017/4216
DEVICES AND METHODS FOR TREATMENT OF TISSUE
Delivery systems, and methods using the same, having an ultrasound viewing window for improved imaging and a needle for ablation treatment of target tissues. In an embodiment, the target tissue is a fibroid within a female's uterus. In an embodiment, the delivery system includes a rigid shaft having a proximal end, a distal end, and an axial passage extending through the rigid shaft. In an embodiment, the axial passage is configured for removably receiving the ultrasound imaging insert having an ultrasound array disposed a distal portion.
DEVICES AND METHODS FOR MINIMALLY INVASIVE SURGERY
The present invention relates to methods and devices for minimally invasive diagnosis and treatment of joint injuries and other injuries or diseases in body joints, tissues, and cavities. Small diameter endoscopic devices are used for visualization and to provide access for the insertion of small diameter surgical tools without the use of distending fluid. Preferred embodiments of the endoscopic devices can utilize wireless transmission to a handheld display device to visualize diagnostic and therapeutic procedures in accordance with the invention.
Apparatus for evaluating the integrity of a uterine cavity
Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO2) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate. If the flow rate drops to zero or close to zero, this indicates that the uterine cavity is intact and not perforated. If the flow rate does not drop to zero or close to zero, this indicates that a fluid flow is leaking through a perforation in the uterine cavity into the uterine cavity or escaping around an occlusion balloon that occludes the cervical canal.
Clam shell surgical stapling loading unit
A clamshell stapling end effector includes first and second jaws and defines an end effector axis. The first jaw has proximal, central, and distal portions. The central portion includes a first tissue contacting surface and defines a cavity. The second jaw includes a second tissue contacting surface and is rotatably secured to the first jaw about a rotation axis. The rotation axis is parallel to the end effector axis. The second jaw has a folded position such that the second jaw is positioned within the cavity of the first jaw with the first and second tissue contacting surfaces parallel to one another and facing in the same direction and a clamped position such that the first and second tissue contacting surfaces oppose one another.
UTERINE FIBROID TISSUE REMOVAL DEVICE
A uterine fibroid tissue removal device includes an inner tube disposed within an outer tube and configured to be translated and rotated relative to the outer tube, and a separately formed unitary distal tip member attached to a distal end of the inner tube, such that the distal tip member translates and rotates relative to the outer tube along with the inner tube, wherein a distal facing open cutting end of the distal tip member in fluid communication with an axial lumen of the distal tip member translates across a tissue resection window in a sidewall of the outer tube so as to sever tissue extending therethrough, the distal tip member axial lumen being in fluid communication with an axial lumen of the inner tube, wherein an outer diameter of the distal tip member is greater than an outer diameter of the inner tube.
Operative Cannulas and Related Methods
An operative cannula includes an elongate shaft that includes a wall structure and a channel extending along the wall structure. The wall structure defines an interior pocket sized to receive a tubular member and is configured to grasp the tubular member when the tubular member is disposed within the interior pocket. The channel is configured to allow passage of an instrument from a proximal end region of the elongate shaft through a distal end region of the elongate shaft.
Intracorporeal transilluminator of tissue using LED array
A device which illuminates internal tissue and organs of a patient. The illumination member includes an array of light-emitting diodes (“LEDs”). The arrangement of the array depends on the configuration of the device and the procedure for which the device is being used. In all cases, the illumination member is used to illuminate relevant organs or structures in the body in order to increase visibility during surgical procedures. The LED array reduces the potential for inadvertent injury to internal structures for procedures located throughout the body. These procedures include those involving the reproductive organs of males and females, gastric and bariatrics, and other structures in the abdomen.
Tissue cutting systems and methods
A probe for resecting and coagulating tissue comprises an outer sleeve having a tissue cutting window and an inner sleeve having a tissue cutting distal end. And RF cutting region is formed at the distal end of the inner member and an RF coagulation region is formed on an exterior surface of the inner member immediately proximal to the cutting surface. A single power supply providing a single RF energy mode can be connected to both RF applicator regions to simultaneously cut and coagulate tissue.
TISSUE RESECTING DEVICE AND METHODS
Devices, systems, and methods for resecting tissue are disclosed. In some embodiments, a tissue resecting device may comprise an elongated structure having a longitudinal axis, the elongated structure comprising an outer sleeve with a distal window configured to receive uterine polyp tissue and an inner sleeve configured to move between a proximal position and a distal position relative to the window. In some further embodiments, the device may also comprise an electrode element coupled to the inner sleeve. In some even further embodiments, the device may include an insulative layer covering at least a portion of the inner sleeve, wherein the tissue resecting device is configured to fail when used to resect tissue more fibrous than uterine polyp tissue.
RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO
A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption. Kits and uterine lavage systems are further provided for performing the processes described in the invention.